🇺🇸 FDA
Patent

US 7731953

Methods for use of TSLP and agonists and antagonists thereof

granted A61KA61K2039/505A61K2239/31

Quick answer

US patent 7731953 (Methods for use of TSLP and agonists and antagonists thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K31/7088